StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
H.C. Wainwright Reiterates Buy Rating on Immuneering Corporation (IMRX)
August 27, 2026 7:08 AM
H.C. Wainwright analyst Andres Maldonado reiterated a Buy rating and $14.00 price target on Immuneering Corporation (NASDAQ: IMRX).The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
